Luna Innovations Inc.: First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy

ROANOKE, Va.--(BUSINESS WIRE)--Researchers from Luna Innovations Incorporated (NASDAQ: LUNA) and Virginia Commonwealth University (VCU) are the first to show that carbon nanospheres, sometimes referred to as “buckyballs,” are able to block allergic response in human cell culture experiments and mice. These findings are described in a paper entitled “Fullerene Nanomaterials Inhibit the Allergic Response” published in the July 1 issue of the Journal of Immunology, setting the stage for the development of new potential therapies for allergies using nanomaterials.
MORE ON THIS TOPIC